A new awareness-raising campaign on skin cancer disseminates the latest research on the most common type of cancer in the US.
Atlanta,United States - November 11, 2022 /PressCable/ —
Dr. Harvey “Chip” Cole III, MD, FACS, continues to educate the public on the most common skin conditions with a new awareness-raising campaign discussing skin cancer risk factors, complications, and treatment options.
More details can be found at https://www.linkedin.com/in/dr-harvey-chip-cole-iii-md-facs-5a86649a
The announcement comes as skin cancer remains the most common type of cancer in the United States, with one in five Americans developing skin cancer in their lifetime. Due to continuous exposure, one of the most common areas cancer appears is the face.
Dr. Cole said: “Skin cancer usually appears on the face or eyelids in the form of painless elevations or nodules. Although eyelid skin cancers may be found anywhere on the eyelids and result in distorted or missing eyelashes, these cancers occur most often on the lower eyelids. Bleeding, crusting, color changes, or distortion of the normal skin structure may also be apparent. Such findings need to be evaluated and may require a biopsy to diagnose whether it is skin cancer.”
Dr. Cole explains that atopic dermatitis (AD), one of the most common skin conditions, can be an additional risk factor for skin cancer. A systematic literature review (1) published in 2022 found a significant association between AD and skin cancer, though the underlying mechanisms are not yet clear.
Treatment for skin cancer will most often include surgery, with recent research (2) suggesting that aggressive excisions and node dissections can be detrimental for squamous cell carcinoma patients. A multidisciplinary approach including oncoplastic surgery and reconstructive procedures can be more effective, says Dr. Cole.
Dr. Cole recommends that all patients experiencing abnormal lesions, moles, or spots on their skin schedule a consult with an experienced dermatologist.
About Dr. Harvey “Chip” Cole
An experienced surgeon with more than three decades of activity, Dr. Cole has completed more than 35,000 surgeries and is internationally recognized as an authority in ophthalmology and facial surgery.
A satisfied client said: “I had a basal cell carcinoma removed from under my eye. Dr. Cole had to do a graft from my upper eyelid to cover the pretty large area. While using the eyelid for the graft he also had to do some fine tuning to the other eyelid to make everything symmetrical. He is a fantastic surgeon, along with his staff, Jesse, Jenny, and Julia – and the whole team are so wonderful and attentive to your needs.”
Interested parties can find more information at https://www.linkedin.com/in/dr-harvey-chip-cole-iii-md-facs-5a86649a
References:
1) Zhu, Y., Wang, H., He, J. et al. Atopic Dermatitis and Skin Cancer Risk: A Systematic Review. Dermatol Ther (Heidelb) 12, 1167-1179 (2022). https://doi.org/10.1007/s13555-022-00720-2
2) Brambullo et al. Current Surgical Therapy of Locally Advanced cSCC: From Patient Selection to Microsurgical Tissue Transplant. Review. Frontiers in Oncology, 11 (2021). DOI=10.3389/fonc.2021.783257
Contact Info:
Name: Media Inquiries
Email: Send Email
Organization: Dr. Harvey "Chip" Cole III, MD, FACS, Quadruple Board Certified Surgeon
Address: 5505 Peachtree Dunwoody Road Ste 630, Atlanta, GA 30342, United States
Website: https://www.drchipcole.com/
Source: PressCable
Release ID: 89084729
If you detect any issues, problems, or errors in this press release content, kindly contact error@releasecontact.com to notify us. We will respond and rectify the situation in the next 8 hours.
